CN Patent

CN105879041A — 一种泊沙康唑口服液及其制备方法

Assigned to Centaurus Biopharma Co Ltd · Expires 2016-08-24 · 10y expired

What this patent protects

本发明公开了一种可提高生物利用度的泊沙康唑口服溶液，其中包含泊沙康唑，或其药学上可接受的盐，改性‑β环糊精，防腐剂，螯合剂，甜味剂，芳香剂和pH调节剂。

USPTO Abstract

本发明公开了一种可提高生物利用度的泊沙康唑口服溶液，其中包含泊沙康唑，或其药学上可接受的盐，改性‑β环糊精，防腐剂，螯合剂，甜味剂，芳香剂和pH调节剂。

Drugs covered by this patent

posaconazole (POSACONAZOLE)

Patent Metadata

Patent number: CN105879041A
Jurisdiction: CN
Classification: —
Expires: 2016-08-24
Drug substance claim: No
Drug product claim: No
Assignee: Centaurus Biopharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.